Genes involved in NER system such as ERCC1 [41, 43–45], ERCC2(XPD), [44, 46] BAG1, [46] XPA, [47] were also reported to be associated with clinical outcomes in NSCLC treated with platinum-based regimen. This evidence concerns the gene BAG1 and non-small cell lung carcinoma.